ECLUNG consensus/guidelines development principles and methods (2024 edition)

Chunwei Xu; Yue Hao; Dong Wang; Shirong Zhang; Wenxian Wang; Qian Wang; Tangfeng Lv; Zhengbo Song; Ziming Li

doi:10.1016/j.ipha.2024.11.004

Intelligent Pharmacy ›› 2025, Vol. 3 ›› Issue (2) : 141 -142. DOI: 10.1016/j.ipha.2024.11.004

Letter to Editor

ECLUNG consensus/guidelines development principles and methods (2024 edition)

Chunwei Xu ¹^,²
, Yue Hao ²^,³
, Dong Wang ²
, Shirong Zhang ⁴
, Wenxian Wang ³
, Qian Wang ⁵
, Tangfeng Lv ²^,^†
, Zhengbo Song ³^,^†
, Ziming Li ⁶^,^†

Author information +

History +

PDF (214KB)

Cite this article

Download citation ▾

Chunwei Xu, Yue Hao, Dong Wang, Shirong Zhang, Wenxian Wang, Qian Wang, Tangfeng Lv, Zhengbo Song, Ziming Li. ECLUNG consensus/guidelines development principles and methods (2024 edition). Intelligent Pharmacy, 2025, 3(2): 141-142 DOI:10.1016/j.ipha.2024.11.004

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Xu C , Si L , Wang W , et al. Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China. Thorac Cancer. 2022; 13 (21): 3084- 3097.

[2]	Wang W , Wang Q , Xu C , et al. Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor. Thorac Cancer. 2022; 13 (23): 3420- 3430.

[3]	Zhang S , Wang W , Xu C , et al. Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer. Thorac Cancer. 2023; 14 (1): 91- 104.

[4]	Xu C , Zhang Y , Wang W , et al. Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors. Thorac Cancer. 2023; 14 (12): 1102- 1117.

[5]	Wang Q , Xu C , Wang W , et al. Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma. Thorac Cancer. 2023; 14 (26): 2715- 2731.

[6]	Pu X , Xu C , Wang Q , et al. Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China. Thorac Cancer. 2023; 14 (31): 3166- 3177.

[7]	Xu C , Wang Q , Wang D , et al. Expert consensus on the diagnosis and treatment of NRG1/2 gene fusion solid tumors. Glob Med Genet. 2024; 11 (1): 86- 99.

[8]	Xu C , Lian B , Ou J , et al. Expert consensus on the diagnosis and treatment of FGFR gene-altered solid tumors. Glob Med Genet. 2024; 11 (4): 330- 343.

[9]	Xu C , Chen Z , Xia Y , et al. Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: an expert consensus in China. Cancer. 2024; 130 (S17): 3054.

[10]	Wang W , Lian B , Xu C , et al. Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations. Innovation. 2024; 5 (6): 100661.